GR
Trans American Aquaculture, Inc.
GRPS · OTC
$0.00 +0.00% (+$0.00)
1M +9,900.00%
Market Cap $180.6K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0
100.0% downside
Current Price
$0.0001
Undervalued Fair Value Overvalued
According to Bulios Fair Price, GRPS is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
71 /100
Cheap P/S 10.95x
P/FCF 0.03x
P/E N/A
Growth
0 /100
Declining Rev. growth 57.43%
EPS growth N/A
Book val. growth N/A
Profitability
50 /100
Moderate Gross margin 972.26%
FCF margin 36,111.40%
Net margin 12,913.80%
Quality
37 /100
Average ROIC 11.96%
Asset turnover 0.01x
ROA 192.54%
Debt
0 /100
High Current ratio 0.07x
Int. coverage -2.08x
Debt/Equity N/A
Stability
1 /100
Unstable Beta 0.16x
Profitable years 0
Rev. volatility 164.61%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GRPS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Adam Thomas
Employees
6
Headquarters
Dallas